Sex and anti-inflammatory treatment affect outcome of melanoma and non-small cell lung cancer patients with rheumatic immune-related adverse events

BACKGROUND: Rheumatic immune-related adverse events (R-irAEs) occur in 5–15% of patients receiving immune checkpoint inhibitors (ICI) and, unlike other irAEs, tend to be chronic. Herein, we investigate the factors influencing cancer and R-irAEs outcomes with particular focus on adverse effects of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Gente, Karolina, Diekmann, Leonore, Daniello, Lea, Will, Julia, Feisst, Manuel, Olsavszky, Victor, Günther, Janine, Lorenz, Hanns-Martin, Souto-Carneiro, M Margarida, Hassel, Jessica C, Christopoulos, Petros, Leipe, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510926/
https://www.ncbi.nlm.nih.gov/pubmed/37730272
http://dx.doi.org/10.1136/jitc-2023-007557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510926/
https://www.ncbi.nlm.nih.gov/pubmed/37730272
http://dx.doi.org/10.1136/jitc-2023-007557

Ejemplares similares